New Radiation-Immunotherapy combo tested for advanced colon cancer

NCT ID NCT06848465

Recruiting now Disease control Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing whether a combination of low-dose radiation, chemotherapy, and immunotherapy is safe and feasible for people with colorectal cancer that has spread only to the liver. The study will enroll 9-18 participants who have not had prior cancer treatment. The main goal is to check for side effects and determine if this multi-pronged approach is tolerable.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Army Medical Center
RECRUITING

Chongqing, Chongqing Municipality, 400042, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Daping Hospital, Army Medical University
ACTIVE_NOT_RECRUITING

Chongqing, Chongqing Municipality, 400042, China

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER LDRT LIVER METASTASIS